Literature DB >> 14973368

Generation of receptor-active, globotriaosyl ceramide/cholesterol lipid 'rafts' in vitro : A new assay to define factors affecting glycosphingolipid receptor activity.

Anita Nutikka1, Clifford Lingwood.   

Abstract

Purified renal globotriaosyl ceramide (Gb3)/cholesterol mixtures sonicated heated in a Triton-containing buffer placed below a discontinuous sucrose gradient form glycosphingolipid (GSL)-containing dense lipid structures at the 30/5% sucrose interface after centrifugation. Inclusion of fluorescein-labeled verotoxin 1 B subunit (FITC-VT1 B) within the most dense sucrose layer results in the fluorescent labeling of this Gb3-containing raft structure. Alternatively inclusion of I-labeled VT1 fractionation allows quantitation of binding. FITC-VT1 B effectively competes for I-VT1/Gb3 raft binding. This assay will allow the definition of the optimal raft composition for VT1 (or any other ligand) binding. The effect of several potential cellular raft components are reported. Increased cholesterol content increased VT1 binding. Addition of phosphatidylethanolamine had minimal effect while phosphatidylserine was inhibitory. Although inclusion of sphingomyelin increased the Gb3 content of the "raft" reduced VT1 binding was seen. Inclusion of other glycolipids can also be inhibitory. The addition of globotetraosyl ceramide had no effect; however addition of sulfogalactosyl ceramide but not sulfogalactoglycerolipid inhibited VT1/Gb3 raft binding. These results suggest that certain GSLs can disfavor the formation of the appropriate 'raft' structure for ligand binding that this is dependent on both their carbohydrate lipid structure. Such "deceptor" GSLs may provide an as yet unappreciated mechanism for the regulation of cellular GSL receptor activity. This model is an effective tool to approach the dynamics ligand-binding specificity of GSL/cholesterol-containing lipid microdomains.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14973368     DOI: 10.1023/B:GLYC.0000016740.69726.fb

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  9 in total

1.  A major fraction of glycosphingolipids in model and cellular cholesterol-containing membranes is undetectable by their binding proteins.

Authors:  Radhia Mahfoud; Adam Manis; Beth Binnington; Cameron Ackerley; Clifford A Lingwood
Journal:  J Biol Chem       Date:  2010-08-17       Impact factor: 5.157

2.  Fatty acid-dependent globotriaosyl ceramide receptor function in detergent resistant model membranes.

Authors:  Radhia Mahfoud; Adam Manis; Clifford A Lingwood
Journal:  J Lipid Res       Date:  2008-08-20       Impact factor: 5.922

Review 3.  Retrograde trafficking of AB₅ toxins: mechanisms to therapeutics.

Authors:  Somshuvra Mukhopadhyay; Adam D Linstedt
Journal:  J Mol Med (Berl)       Date:  2013-05-12       Impact factor: 4.599

4.  Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease.

Authors:  Tom G Obrig
Journal:  Toxins (Basel)       Date:  2010-12-02       Impact factor: 4.546

5.  Glycosphingolipid storage in Fabry mice extends beyond globotriaosylceramide and is affected by ABCB1 depletion.

Authors:  Mustafa A Kamani; Philippe Provençal; Michel Boutin; Natalia Pacienza; Xin Fan; Anton Novak; Tonny C Huang; Beth Binnington; Bryan C Au; Christiane Auray-Blais; Clifford A Lingwood; Jeffrey A Medin
Journal:  Future Sci OA       Date:  2016-10-13

6.  Altered dynamics of a lipid raft associated protein in a kidney model of Fabry disease.

Authors:  Anatália Labilloy; Robert T Youker; Jennifer R Bruns; Ira Kukic; Kirill Kiselyov; Willi Halfter; David Finegold; Semiramis Jamil Hadad do Monte; Ora A Weisz
Journal:  Mol Genet Metab       Date:  2013-10-19       Impact factor: 4.797

7.  Platelets recognize brain-specific glycolipid structures, respond to neurovascular damage and promote neuroinflammation.

Authors:  Ilya Sotnikov; Tatyana Veremeyko; Sarah C Starossom; Natalia Barteneva; Howard L Weiner; Eugene D Ponomarev
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

8.  Tumor-specific Hsp70 plasma membrane localization is enabled by the glycosphingolipid Gb3.

Authors:  Mathias Gehrmann; Gerhard Liebisch; Gerd Schmitz; Robin Anderson; Claudia Steinem; Antonio De Maio; Graham Pockley; Gabriele Multhoff
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

9.  A new family of potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia coli.

Authors:  Adrienne W Paton; Potjanee Srimanote; Ursula M Talbot; Hui Wang; James C Paton
Journal:  J Exp Med       Date:  2004-06-28       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.